202 related articles for article (PubMed ID: 16145209)
1. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.
Torres LN; Matera JM; Vasconcellos CH; Avanzo JL; Hernandez-Blazquez FJ; Dagli ML
Vet Pathol; 2005 Sep; 42(5):633-41. PubMed ID: 16145209
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
3. Expression of connexins in normal and neoplastic canine bone tissue.
Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
[TBL] [Abstract][Full Text] [Related]
5. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
7. P-cadherin expression in canine mammary tissues.
Gama A; Paredes J; Albergaria A; Gartner F; Schmitt F
J Comp Pathol; 2004 Jan; 130(1):13-20. PubMed ID: 14693120
[TBL] [Abstract][Full Text] [Related]
8. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin immunoreactivity in canine mammary tumors.
Sarli G; Preziosi R; De Tolla L; Brunetti B; Benazzi C
J Vet Diagn Invest; 2004 Nov; 16(6):542-7. PubMed ID: 15586569
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of parathyroid hormone-related protein in canine mammary tumors.
Okada H; Nishijima Y; Yoshino T; Grone A; Capen CC; Rosol TJ
Vet Pathol; 1997 Jul; 34(4):356-9. PubMed ID: 9240847
[TBL] [Abstract][Full Text] [Related]
11. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia.
Sawey MJ; Goldschmidt MH; Risek B; Gilula NB; Lo CW
Mol Carcinog; 1996 Oct; 17(2):49-61. PubMed ID: 8890953
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue.
Dias Pereira P; Gärtner F
Vet Rec; 2003 Sep; 153(10):297-302. PubMed ID: 14509576
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
16. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
[TBL] [Abstract][Full Text] [Related]
17. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
18. E cadherin expression in normal and neoplastic canine mammary gland.
Restucci B; Papparella S; De Vico G; Maiolino P
J Comp Pathol; 1997 Feb; 116(2):191-202. PubMed ID: 9131434
[TBL] [Abstract][Full Text] [Related]
19. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
20. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
